Overview

MESS-study MRSA Eradication Study Skåne

Status:
Completed
Trial end date:
2015-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether systemic antibiotic treatment with rifampicin and clindamycine or trimethoprim-sulfa in addition to topical treatment with mupirocin is more effective than only topical treatment to eradicate MRSA in throatcarriers
Phase:
N/A
Details
Lead Sponsor:
Region Skane
Treatments:
Mupirocin
Rifampin
Trimethoprim, Sulfamethoxazole Drug Combination